Target Name: MIR6792
NCBI ID: G102465475
Review Report on MIR6792 Target / Biomarker Content of Review Report on MIR6792 Target / Biomarker
MIR6792
Other Name(s): MicroRNA 6792 | hsa-miR-6792-3p | hsa-miR-6792-5p | hsa-mir-6792 | microRNA 6792

miRNA-6792: A Promising Drug Target and Biomarker

MicroRNA 6792 (miRNA-6792) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

The miRNA-6792 molecule is composed of 20 amino acid residues and has a unique structure that consists of a stem-loop and a 3' end. The stem-loop is a common structural element in miRNAs and is responsible for maintaining the stability of the molecule. The 3' end of the molecule has a unique structure that includes a loop and a terminal phosphate group, which is important for the stability and function of the molecule.

One of the most significant features of mi-6792 is its ability to interact with other molecules and proteins. This interaction is critical for the function of the molecule and has been shown to play a role in several diseases. For example, studies have shown that mi-6792 can interact with the protein IDH1, which is a gene that is involved in the development of cancer. When mi-6792 is introduced into cancer cells, it can inhibit the activity of IDH1 and reduce the formation of cancer cells.

Another study has shown that mi-6792 can interact with the protein NLRP1. NLRP1 is a protein that is involved in the regulation of stress responses and is considered a potential drug target for several diseases, including neurodegenerative disorders. When mi-6792 is introduced into neurodegenerative cells, it can interact with NLRP1 and reduce the formation of neurodegenerate cells.

In addition to its potential interactions with other molecules, mi-6792 has also been shown to have unique functional properties. For example, studies have shown that mi-6792 can be used as a potential drug target because it is highly expressed in cancer cells and has a low expression in normal cells. This allows researchers to focus their efforts on targeting the molecule in cancer cells and reduce the risk of toxic side effects in normal cells.

Another study has shown that mi-6792 can be used as a potential biomarker for cancer. The expression of mi-6792 has been shown to be elevated in several types of cancer, including breast, ovarian, and colorectal cancer. This makes it a potential diagnostic biomarker for these diseases and could be used in the development of new treatments.

In conclusion, miRNA-6792 is a unique and promising molecule that has been identified as a potential drug target and biomarker for several diseases. Its interaction with other molecules and its unique functional properties make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of mi-6792 in diseases and to develop new treatments based on this molecule.

Protein Name: MicroRNA 6792

The "MIR6792 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6792 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800 | MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808 | MIR6809 | MIR6810 | MIR6811 | MIR6812 | MIR6813 | MIR6814 | MIR6815 | MIR6816 | MIR6817 | MIR6818 | MIR6819 | MIR6820 | MIR6821 | MIR6822 | MIR6823 | MIR6824 | MIR6825 | MIR6826 | MIR6827 | MIR6828 | MIR6829 | MIR6830 | MIR6831 | MIR6832 | MIR6833 | MIR6834 | MIR6836 | MIR6837 | MIR6839 | MIR6840 | MIR6841 | MIR6842 | MIR6843 | MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4 | MIR6860 | MIR6861 | MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890